Dmitry Balyasny’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Dmitry Balyasny’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-157,843	Closed	-$8.44M	–	1673
2016 Q1	$8.44M	Buy	157,843 +155,693	+7,242%	+$11.5M	0.05%	439
2015 Q4	$243K	Sell	2,150 -3,660	-63%	-$403K	﹤0.01%	1038
2015 Q3	$684K	Buy	5,810 +530	+10%	+$69.2K	0.01%	775
2015 Q2	$409K	Buy	+5,280	New	+$346K	﹤0.01%	895

Other funds holding ANAC

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Dmitry Balyasny's ANAC Position: Q2 2016 in Review

Dmitry Balyasny sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 157,843 shares — an estimated $8.44M sold.

Dmitry Balyasny first reported a position in ANAC in Q2 2015 and held it in 4 quarters. The position peaked at $8.44M in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Dmitry Balyasny reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Dmitry Balyasny sold 157,843 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $8.44M.
Dmitry Balyasny first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 4 quarters.
Dmitry Balyasny's ANACOR PHARMACEUTICALS INC COM position peaked at $8.44M in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Balyasny Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.